January 28, 2026
Finance

Wall Street Analysts Revise Price Targets for Major Industrials and Healthcare Stocks

General Motors and Boeing Among Companies Seeing Notable Price Target Adjustments

Loading...
Loading quote...

Summary

Several leading Wall Street analysts have updated their price targets on key stocks within the industrials and healthcare sectors. These revisions reflect changing views on company valuations but maintain generally positive outlooks. Notably, General Motors, Boeing, and Northrop Grumman all received upward price target adjustments, signaling confidence in their market prospects.

Key Points

Northrop Grumman, Boeing, and General Motors had their price targets raised significantly.
General Motors' new price target suggests more than 27% potential upside from current stock price.
Healthcare stocks HCA Healthcare and Bristol-Myers Squibb received positive price target revisions.
Deutsche Bank upgraded Texas Instruments' price target but kept a Hold rating, indicating measured confidence.

On Tuesday, prominent Wall Street analysts recalibrated their view on various major companies, adjusting their price targets while largely maintaining bullish or positive ratings. The updated forecasts span a diverse range of industries including aerospace, defense, automotive, healthcare, technology, and logistics.

Starting with the aerospace and defense segment, BTIG analyst Andre Madrid elevated Northrop Grumman Corp's (NYSE:NOC) price target from $680 to $815, while maintaining a Buy rating. This revision came as Northrop Grumman’s shares closed at $678.74 on Tuesday, indicating that the analyst sees significant upside potential beyond the current stock price.

Similarly, Citigroup's John Godyn boosted the price target for Boeing Co (NYSE:BA) from $270 to $290 and reiterated a Buy rating. Boeing closed at $244.56 on the same day, suggesting room for potential gains based on Citigroup’s updated evaluation.

In the healthcare sector, Oppenheimer analyst Michael Wiederhorn raised HCA Healthcare Inc’s (NYSE:HCA) price target to $540 from $500, retaining an Outperform stance. HCA Healthcare’s shares ended Tuesday trading at $505.84, reflecting investor sentiment alongside the increased valuation estimate.

Turning to the automotive industry, Barclays analyst Dan Levy elevated General Motors Co's (NYSE:GM) price target from $100 to $110 and maintained an Overweight rating. General Motors shares closed at $86.38 on Tuesday, indicating that Barclays anticipates a substantial appreciation potential exceeding 27% from current levels.

Foodservice distribution company Sysco Corp (NYSE:SYY) also experienced an upward revision as Wells Fargo analyst Edward Kelly raised its price target from $88 to $92 and kept an Overweight rating. Sysco’s shares closed at $83.92, highlighting modest upside according to analyst expectations.

Conversely, Citigroup’s George Kurosawa adjusted down the price target for Roper Technologies Inc (NYSE:ROP) from $575 to $450, even though the Buy rating was maintained. Roper’s shares closed at $369.27, suggesting that the analyst has tempered expectations for the stock’s near-term performance.

Within the technology sector, Deutsche Bank analyst Ross Seymore uplifted Texas Instruments Inc’s (NASDAQ:TXN) price target from $185 to $205 but maintained a Hold rating. Texas Instruments shares closed at $196.63, a figure that sits between the prior and new price targets, reflecting a cautious yet constructive outlook.

Stifel analyst J. Bruce Chan enhanced the target price for United Parcel Service Inc’s (NYSE:UPS) stock from $112 to $116, continuing to recommend a Buy rating. UPS shares closed at $107.20 on Monday, indicating the potential for share appreciation aligned with the analyst’s forecast.

Storage technology provider Seagate Technology Holdings PLC (NASDAQ:STX) saw a notable price target increase from $370 to $500 by Rosenblatt analyst Kevin Cassidy, who retains a Buy rating. Seagate’s shares ended trading on Tuesday at $371.76, reflecting significant expected growth as per the analyst’s evaluation.

Medical giant Bristol-Myers Squibb Co (NYSE:BMY) had its price target raised from $62 to $66 by Piper Sandler analyst David Amsellem, who preserved an Overweight rating. Bristol-Myers Squibb shares closed at $55.56, suggesting notable upside potential.

These updates illustrate a general trend of rising price targets across many large-cap stocks in sectors ranging from defense to healthcare to technology. Analysts communicate continued confidence in their favorable business outlooks and earnings trajectories, despite varying degrees of caution as highlighted by certain hold ratings and the notable price target reduction for Roper Technologies.


Key Points:

  • Northrop Grumman, Boeing, and General Motors saw notable price target increases reflecting analyst optimism.
  • General Motors’ price target increase from $100 to $110 implies a potential stock gain of over 27% from current levels.
  • Price targets for healthcare companies such as HCA Healthcare and Bristol-Myers Squibb also increased amid sustained positive analyst ratings.
  • Deutsche Bank’s hold rating for Texas Instruments comes alongside a raised price target, signaling cautious optimism.

Risks and Uncertainties:

  • Some revised price targets may incorporate optimistic assumptions not guaranteed to materialize, as evidenced by varying analyst ratings from Buy to Hold.
  • The lowered price target for Roper Technologies indicates market or company-specific challenges that could impact stock performance.
  • Market volatility and sector-specific headwinds could alter realized stock returns relative to analyst price target projections.
  • Price targets are forecasts that might not fully reflect sudden economic or operational shifts in these companies’ business environments.
Risks
  • Some price targets may be based on optimistic assumptions that are not assured to occur.
  • Roper Technologies had its price target lowered, signaling possible company-specific or market challenges.
  • Market volatility could affect whether stocks reach their forecasted price targets.
  • Price targets are forecasts and may not account for sudden changes in business or economic conditions.
Disclosure
Education only / not financial advice
Search Articles
Category
Finance

Financial News

Ticker Sentiment
NOC - positive BA - positive HCA - positive GM - positive SYY - positive
Related Articles
Becton Dickinson Faces Market Headwinds Amid Transition and Revised Earnings Projections

Becton Dickinson & Co. posted first-quarter earnings above analyst expectations but trimmed its fisc...

Major U.S. Stocks Climb Following Strong Earnings Reports and Positive Guidance

U.S. equity markets moved higher on Tuesday, driven by Datadog's significant share price increase fo...

Figma Shares Climb as Analysts Predict Software Sector Recovery

Figma Inc's stock experienced a notable uptick amid a broader rally in software equities. Analysts a...

Oscar Health Targets Profitability in 2026 Following Challenging 2025

Oscar Health Inc. reported fourth-quarter revenue growth driven by expanding membership but faced in...

SoFi Shares Slip Slightly Despite Strong Q4 Earnings and Bullish Outlook

SoFi Technologies Inc’s stock saw a minor decline Tuesday afternoon following a period of heighten...

Quest Diagnostics Reports Strong Q4 Earnings and Raises Full-Year Guidance Driving Stock Higher

Quest Diagnostics posted fourth-quarter results surpassing both earnings and revenue expectations, d...